Various types of dinuclear cobalt(II) complexes, [Co2L(CH3COO)2]ClO4, [Co2L(CH3COO)](ClO4)2, [CO2L(OH)](ClO4)2, [Co2L(C3H3N2)]ClO4)2(C3H3N2−)=pyrazolate), and [CO2LX2](ClO4)n, were prepared, where HL represents 2,6-bis[bis(2-pyridylmethyl)aminomethyl]-4-methylphenol(Hbpmp), 2,6-bis[N-(2-pyridylmethyl)-2-(2-pyridyl)ethylaminomethyl]-4-methylphenol(Hbpmep), 2,6-bis[bis[2-(2-pyridyl)ethyl]aminomethyl]-4-methylphenol(Hbpmep), and 2,6-bis[bis(2-benzirnidazolylmethyl)aminometnyl]-4-metnylphenol(Hbbimp), and X is N3−, NCS−, Cl−, Br−, H2O, or py(pyridine). The electronic spectra and magnetic moments of the complexes revealed that [Co2L(CH3COO)2]ClO4 (L=bpmp, bpmep, or bpep) are high-spin octahedral, whereas the other complexes have five-coordinate structure of high-spin configuration. Some of the bpmp and the bpmep complexes reacted reversibly with molecular oxygen more or less. The P1⁄2 of some complexes were determined spectrometrically. The oxygen affinities of the complexes are highly dependent on the natures of the dinucleating ligands and additional bridging or unidentate ligands.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (1984) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: